Issued Patents All Time
Showing 25 most recent of 28 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11814421 | Truncated von Willebrand Factor polypeptides for treating hemophilia | Stefan Schulte, Thomas Weimer, Sabine Pestel, Steve Dower | 2023-11-14 |
| 11554156 | Pharmaceutical formulations of C1 esterase inhibitor | Ernst-Juergen Kanzy | 2023-01-17 |
| 11510968 | Method for improving the stability of purified Factor VIII after reconstitution | Carsten Horn, Sabine Zollner, Stefan Schulte | 2022-11-29 |
| 11479578 | Protein purification and virus inactivation with alkyl glycosides | Tobias BRANDT, Carsten Horn, Thomas Nowak | 2022-10-25 |
| 10881717 | Method for improving the stability of purified Factor VIII after reconstitution | Carsten Horn, Sabine Zollner, Stefan Schulte | 2021-01-05 |
| 10688157 | Truncated von Willebrand factor polypeptides for treating hemophilia | Stefan Schulte, Sabine Pestel, Thomas Weimer | 2020-06-23 |
| 10537616 | Method for improving the stability of purified factor VIII after reconstitution | Carsten Horn, Sabine Zollner, Stefan Schulte | 2020-01-21 |
| 10238718 | Factor VIII formulation | Uwe Liebing, Christina Bodenbender | 2019-03-26 |
| 9956269 | Method for improving the stability of purified factor VIII after reconstitution | Carsten Horn, Sabine Zollner, Stefan Schulte | 2018-05-01 |
| 9878017 | Covalent complex of von Willebrand Factor and factor VIII, compositions, and uses relating thereto | Stefan Schulte, Thomas Weimer | 2018-01-30 |
| 9511123 | Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor VIII | Sabine Zollner | 2016-12-06 |
| 9393289 | Use of sulfated glycosaminoglycans for improving the bioavailability of factor VIII | Sabine Zollner | 2016-07-19 |
| 9394353 | Method for improving the stability of purified factor VIII after reconstitution | Carsten Horn, Sabine Zollner, Stefan Schulte | 2016-07-19 |
| 9290561 | Factor VIII, von Willebrand factor or complexes thereof with prolonged in vivo half-life | Thomas Weimer, Stefan Schulte, Ulrich Kronthaler, Holger Lind, Wiegand Lang | 2016-03-22 |
| 8754194 | Modified coagulation factors with prolonged in vivo half-life | Stefan Schulte, Thomas Weimer | 2014-06-17 |
| 8575104 | Factor VIII, von willebrand factor or complexes thereof with prolonged in vivo half-life | Thomas Weimer, Stefan Schulte, Ulrich Kronthaler, Holger Lind, Wiegand Lang | 2013-11-05 |
| 8012728 | Thrombin preparations and process for their production | Heinrich Scheider | 2011-09-06 |
| 7939288 | Method for differentiating between factor XIII deficiency states and fibrinogen deficiency states by means of thrombelastographic techniques | Erhardt Wrabetz, Wolfgang Korte | 2011-05-10 |
| 7939632 | Proteolytically cleavable fusion proteins with high molar specific activity | Thomas Weimer, Stefan Schulte | 2011-05-10 |
| 7550567 | Fibrinogen purification | Uwe Liebing, Annette Feussner, Joerg Lemmer, Stefan Schulte, Volker Gawantka | 2009-06-23 |
| 7351561 | Thrombin preparations and process for their production | Heinrich Scheider | 2008-04-01 |
| 7276235 | Tissue glue with improved antiadhesive properties | Peter Gronski, Gerhard Dickneite, Monika Kroez | 2007-10-02 |
| 7045601 | Storage-stable, liquid fibrinogen formulation | Uwe Liebing, Gerhardt Kumpe, Stefan Schulte, Volker Gawantka, Karlheinz Enssle | 2006-05-16 |
| 6874657 | Biological sealant storage and dispensing system | Stewart Fox | 2005-04-05 |
| 6790410 | Use of a hydrogen peroxide plasma sterilization method for the mild sterilization of temperature-sensitive products | Joerg Lemmer, Horst Naumann | 2004-09-14 |